Nivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleNivolumab in Eliminating Minimal Residual Disease and Preventing Relapse in Patients With Acute Myeloid Leukemia in Remission After Chemotherapy
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsDaruka Mahadevan